NO20032609D0 - Fremgangsmåte for testing av hormonelle effekter av substanser - Google Patents

Fremgangsmåte for testing av hormonelle effekter av substanser

Info

Publication number
NO20032609D0
NO20032609D0 NO20032609A NO20032609A NO20032609D0 NO 20032609 D0 NO20032609 D0 NO 20032609D0 NO 20032609 A NO20032609 A NO 20032609A NO 20032609 A NO20032609 A NO 20032609A NO 20032609 D0 NO20032609 D0 NO 20032609D0
Authority
NO
Norway
Prior art keywords
foxg1c
substances
testing
hormonal effects
receptor
Prior art date
Application number
NO20032609A
Other languages
English (en)
Inventor
Siegmund Wolf
Maik Obendorf
Original Assignee
Jenapharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jenapharm Gmbh filed Critical Jenapharm Gmbh
Publication of NO20032609D0 publication Critical patent/NO20032609D0/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
NO20032609A 2002-06-12 2003-06-10 Fremgangsmåte for testing av hormonelle effekter av substanser NO20032609D0 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10226674A DE10226674B4 (de) 2002-06-12 2002-06-12 Verfahren zur Testung des hormonellen Effekts von Substanzen

Publications (1)

Publication Number Publication Date
NO20032609D0 true NO20032609D0 (no) 2003-06-10

Family

ID=27588642

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032609A NO20032609D0 (no) 2002-06-12 2003-06-10 Fremgangsmåte for testing av hormonelle effekter av substanser

Country Status (9)

Country Link
US (1) US20040009524A1 (no)
EP (1) EP1376136B1 (no)
JP (1) JP2004016236A (no)
AT (1) ATE320608T1 (no)
DE (2) DE10226674B4 (no)
DK (1) DK1376136T3 (no)
ES (1) ES2260548T3 (no)
NO (1) NO20032609D0 (no)
PT (1) PT1376136E (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005042574A1 (en) * 2003-11-03 2005-05-12 Acadia Pharmaceuticals Inc. High troughput functional assay for g-protein coupled receptors using a rap-ras chimeric protein
JP2008520244A (ja) * 2004-11-19 2008-06-19 アカディア ファーマシューティカルズ インコーポレイテッド ホルモン核内受容体のリガンドの同定方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO20021900L (no) * 2001-05-04 2002-11-05 Jenapharm Gmbh FremgangsmÕte for analyse av forbindelsers hormonvirkning

Also Published As

Publication number Publication date
DE10226674A1 (de) 2004-01-08
DE50302644D1 (de) 2006-05-11
DE10226674B4 (de) 2006-01-05
EP1376136A3 (de) 2004-01-14
DK1376136T3 (da) 2006-07-10
ES2260548T3 (es) 2006-11-01
EP1376136A2 (de) 2004-01-02
PT1376136E (pt) 2006-07-31
ATE320608T1 (de) 2006-04-15
EP1376136B1 (de) 2006-03-15
JP2004016236A (ja) 2004-01-22
US20040009524A1 (en) 2004-01-15

Similar Documents

Publication Publication Date Title
Clark et al. Glucocorticoid modulation of tryptophan hydroxylase-2 protein in raphe nuclei and 5-hydroxytryptophan concentrations in frontal cortex of C57/Bl6 mice
NO20081164L (no) Maler med ettermaltids testtidsalarm
SG126066A1 (en) Inspection method and system using multifrequency phase analysis
GB2431013A (en) Method and apparatus for sensing a time varying current passing through an ion channel
Raudensky et al. Effects of chronic unpredictable stress and methamphetamine on hippocampal glutamate function
IL182997A0 (en) Non-invasive measurement system and method for measuring the concentration of an optically-active substance
DE69920940D1 (de) Verfahren zur überwachung der proteasomeinhibitorarzneimitteleffekte
DK2110666T3 (da) Hidtil ukendt fremgangsmåde til at detektere og analysere proteininteraktioner in vivo
DE602005020446D1 (de) Konfokale flüssigkeitsstandmessung
WO2005080967A8 (en) Method and device for the characterization of interactions between different species
FI20010533A (fi) Kanavakoodekkien testisilmukoita
ATE490469T1 (de) Beurteilung des skelettwachstums unter verwendung von messungen von nt-cnp-peptiden
Christiansen et al. Disturbed diurnal rhythm of three classical phase markers in the chronic mild stress rat model of depression
Günther et al. Effects of chronic citalopram treatment on 5-HT1A and 5-HT2A receptors in group-and isolation-housed mice
ATE438098T1 (de) Teststreifen enthaltend kontrollmittel und zeitsetzermittel
NO20032609D0 (no) Fremgangsmåte for testing av hormonelle effekter av substanser
Rabbani et al. Increase in brain corticosterone concentration and recognition memory impairment following morphine withdrawal in mice
TR200402024T4 (tr) Maddelerin hormon etkisini test yöntemi
Jacobsen et al. The efficacy of (+)-Naltrexone on alcohol preference and seeking behaviour is dependent on light-cycle
Martin et al. Key role of the 5-HT1A receptor addressing protein Yif1B in serotonin neurotransmission and SSRI treatment
O'Brien et al. Measuring d‐serine efflux from mouse cortical brain slices using online microdialysis‐capillary electrophoresis
DE50300480D1 (de) Verfahren zur Testung des hormonellen Effekts von Substanzen
Aluf et al. Specific oxidative stress profile associated with partial striatal dopaminergic depletion by 6-hydroxydopamine as assessed by a novel multifunctional marker molecule
Jangir et al. Reducing Public Speaking Anxiety with Behavior Modification Techniques among School Students: A Study
Higuchi et al. Augmentation of serotonin release by sustained exposure to MDMA and methamphetamine in rat organotypic mesencephalic slice cultures containing raphe serotonergic neurons

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application